Market Overview

AstraZeneca Sharply Higher Off Positive Data For Imfinzi


AstraZeneca plc (ADR) (NYSE: AZN) shares are trading higher by $2.33 (8 percent) at $33.45 in Friday's session.

The catalyst for the rally is the announcement that its drug, Imfinzi, has met primary endpoint for the treatment of lung cancer.

After a much higher open, AstraZeneca had only a 3-cent retreat to $33.17 before continuing its move higher. So far, the ensuing rally has taken the stock to $34.03, but has fallen back into the mid $33.00 handle.

The current high coincides with its September 28 high of $34.09.

Posted-In: ImfinziTechnicals Intraday Update Movers Trading Ideas


Related Articles (AZN)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

Bipartisan Group Of Senators Working On Fannie And Freddie Behind The Scenes

The Teenage Existential Crisis: In Memory Of Our First AOL Instant Messenger Screen Names